
Novo Nordisk eyes Rs 8,600 crore India sales with weight-loss drug Wegovy
Danish pharma giant Novo Nordisk is preparing for a major push in India with its blockbuster weight-loss drug Wegovy (semaglutide), according to a report by The Economic Times. The company is targeting sales of $1 billion (around Rs 8,600 crore) in the …